Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

LIGELIZUMAB — Molecular Profile | Crick

Molecules/LIGELIZUMAB

LIGELIZUMAB

Molecular Identity

LIGELIZUMAB

ChEMBL ID: CHEMBL2109457

AntibodyPhase 3

Mechanism of action: Ig epsilon chain C region inhibitor

Properties

Molecular Formula

0.00

Molecular Weight

g/mol

Synonyms(3)

LIGELIZUMABQGE-031QGE031

Data from ChEMBL (EMBL-EBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Drug Network

Trials and conditions connected to LIGELIZUMAB

Loading drug network...